Which statement about the identification and management of adverse drug reactions is FALSE?

The statement regarding adverse events being reported only after patients started complaining of these occurrences is misleading and illustrates a misunderstanding of how adverse drug reactions (ADRs) should be managed. In reality, adverse drug reactions can be identified and reported proactively through careful monitoring, clinical assessments, and pharmacovigilance, rather than relying solely on patient complaints. Healthcare providers are trained to recognize potential side effects based on clinical knowledge and patient history, which leads to the timely identification of adverse events even before patients express concerns.

Additionally, continuous education and monitoring can help in early detection and management of side effects, making it clear that a reactive approach—waiting for patients to complain—is not sufficient. This understanding highlights the importance of proactive management in ensuring patient safety and adherence to treatment, which is a key component of effective healthcare practices, especially in programs such as the National Tuberculosis Control Program. Timely intervention can significantly reduce the likelihood of adverse reactions affecting patient compliance and treatment outcomes.